Journal ID (nlm-ta): Skin Appendage Disord
Journal ID (iso-abbrev): Skin Appendage Disord
Journal ID (publisher-id): SAD
Title:
Skin Appendage Disorders
Publisher:
S. Karger AG
(Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland
· Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.com
)
ISSN
(Print):
2296-9195
ISSN
(Electronic):
2296-9160
Publication date
(Electronic):
8
December
2021
Publication date PMC-release: 8
December
2021
Volume: 130
Issue: 43
Pages: 1-4
Affiliations
[1]
aDepartment of Dermatology, Weill Cornell Medicine, New York, New York, USA
[2]
bCenter for Medical Mycology, Department of Dermatology, Case Western Reserve University
and University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA
[3]
cDepartment of Dermatology, University of Wisconsin School of Medicine and Public Health,
Madison, Wisconsin, USA
[4]
dDepartment of Dermatology, Dermatology, Oregon Health and Science University, Portland,
Oregon, USA
[5]
eDepartment of Dermatology and Pathology, University of California, San Francisco,
California, USA
[6]
fPalo Alto Medical Foundation, Palo Alto, California, USA
[7]
gDepartment of Podiatric Medicine, Temple University School of Podiatric Medicine,
Philadelphia, Pennsylvania, USA
Author notes
Article
Publisher ID:
sad-0130-0001
DOI: 10.1159/000520628
PMC ID: 8805071
PubMed ID: 35127838
SO-VID: e4d44e19-7b00-430e-9c7a-002a502c46fc
Copyright © Copyright © 2021 by S. Karger AG, Basel
License:
This article is licensed under the Creative Commons Attribution 4.0 International
License (CC BY). Usage, derivative works and distribution are permitted provided that
proper credit is given to the author and the original publisher. Drug Dosage: The
authors and the publisher have exerted every effort to ensure that drug selection
and dosage set forth in this text are in accord with current recommendations and practice
at the time of publication. However, in view of ongoing research, changes in government
regulations, and the constant flow of information relating to drug therapy and drug
reactions, the reader is urged to check the package insert for each drug for any changes
in indications and dosage and for added warnings and precautions. This is particularly
important when the recommended agent is a new and/or infrequently employed drug. Disclaimer:
The statements, opinions and data contained in this publication are solely those of
the individual authors and contributors and not of the publishers and the editor(s).
The appearance of advertisements or/and product references in the publication is not
a warranty, endorsement, or approval of the products or services advertised or of
their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility
for any injury to persons or property resulting from any ideas, methods, instructions
or products referred to in the content or advertisements.